Healthcare -
Biotechnology - NASDAQ - US
$ 1.565
7.19 %
$ 101 M
Market Cap
-1.01
P/E
INZY - NET CHANGE IN CASH
Net Change in Cash INZY - Inozyme Pharma, Inc.
1.63 M
LAST VALUE
53.14%
2 YEAR CAGR
-44.70%
5 YEAR CAGR
0.00%
10 YEAR CAGR